Controversial US-backed vaccine trial in African newborns halted
OMEGAZEPRIME News
This story was selected and curated by our editorial team in the Africa category. Published on October 21, 2026 • Originally reported by Melody Schreiber. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
This story was selected and curated by our editorial team in the Africa category. Published on October 21, 2026 • Originally reported by Melody Schreiber. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’
The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday.
It is “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.”
Continue reading...OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com